Highlights
- Indoco Remedies shares dropped over 6% after FY26 quarterly earnings disappointed investors.
- The company reported a consolidated net loss for the March 2026 quarter.
- Technical indicators show near-term volatility after the recent sharp rally in the stock.
Overview
Indoco Remedies (NSE: INDOCO) declined sharply on May 8, with the stock trading near INR 234.35, down 6.50% during the session. The selling pressure emerged after investors reacted to the company’s March 2026 quarterly results, which reflected weak profitability and a consolidated net loss.
The stock had recently witnessed a strong rebound from lower levels near INR 170 before facing profit booking near the INR 250 zone. The latest earnings update appears to have triggered caution among traders amid concerns around margins and earnings visibility.
Earnings Pressure Weighs on Sentiment
For the quarter ended March 2026, Indoco Remedies reported consolidated total income of INR 47,557 crore. However, the company posted a loss before tax of INR 2,500 crore and a consolidated net loss of INR 2,368 crore. Earnings per share came in at negative INR 2.57.
The weak earnings performance appears to have affected market sentiment despite the stock’s recent recovery momentum. Investors are closely watching whether operational performance improves in upcoming quarters.
Price Action Turns Volatile
Indoco Remedies opened near INR 242.00 and touched an intraday low around INR 230.20. The stock remains above its 50-day SMA near INR 202.02, indicating that the broader short-term structure is still relatively positive despite the sharp intraday decline.
The recent rally had pushed momentum indicators into elevated territory, and the latest correction suggests traders may be booking profits after the rapid upside move seen in April and early May.
Technical View
The stock is currently trading near INR 234.35 and remains above its 50-day SMA around INR 202.02, indicating that the broader near-term structure is still constructive despite fresh selling pressure. Price action reflects volatility after the recent rebound toward the INR 250 zone. The 14-day RSI is near 63.47, showing momentum has eased from overbought levels but remains relatively firm. Immediate support is placed around INR 210–190, while resistance is seen near INR 255–270.
Key Technical Levels
- Support Zone: INR 210–190
- Resistance Zone: INR 255–270
- 50-day SMA: INR 202.02
- RSI (14-day): 63.47
Risks to Watch
- Weak earnings trend may affect near-term investor sentiment.
- Profit-booking pressure could increase after recent sharp rally.
- Margin pressure may continue impacting profitability.
- Volatility may remain elevated around quarterly updates.
Summary
Indoco Remedies shares came under pressure after the company reported weak March 2026 quarterly earnings and a consolidated net loss. The stock corrected sharply following a recent rally, reflecting cautious market sentiment around profitability trends. While the stock remains above key moving averages, traders are watching whether support levels hold amid continued volatility and earnings-related concerns.
FAQs
- Why did Indoco Remedies shares fall today?
The stock declined after the company reported weak quarterly earnings and a consolidated net loss for March 2026. - What are the important support levels for INDOCO?
Immediate support for the stock is placed around INR 210–190 based on current technical structure. - What resistance levels should investors watch?
Resistance for Indoco Remedies is seen near the INR 255–270 range after the recent rally attempt.